
OGT - Precision genomic solutions
Accelerate your clinical trial assay and CDx development programmes in haematological malignancies by partnering with OGT’s precision medicine team Discover more
Find out about OGT
Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter.
Company information | OGT
Learn about OGT's quality assurance and social responsibility and get access to legal information including the website terms of use and privacy policy.
OGT company news
Nov 10, 2025 · Find out about the latest news from OGT, including product launches and updates, new research projects, and other major company updates.
OGT delivers superior MRD detection capabilities | OGT news
Jan 22, 2025 · OGT, a Sysmex Group company, is a leading global provider of clinical and diagnostic genomic solutions that are created for scientists by scientists - including CytoCell ®, CytoSure ® and …
Careers | OGT
Want to know why OGT is such a great place to work? Here you can discover more about the different teams that make OGT tick, including R&D, Computational Biology and Operations.
CytoCell fluorescence in situ hybridisation (FISH) - OGT
Developed by scientists, for scientists, OGT's CytoCell ® portfolio offers a comprehensive range of over 545 FISH probes for haematology, solid tumour, cytogenetics and rare disease, supported by our …
SureSeq Myeloid MRD NGS Panel - OGT
OGT specializes in the development of superior hybrid capture technology that excels in the detection of complex structural variants and eliminates inaccurate calls caused by alternative PCR-based …
CytoCell MLL (KMT2A) Breakapart FISH Probe - OGT
Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter.
CytoCell fluorescence in situ hybridization (FISH) - OGT
Developed by scientists, for scientists, OGT's CytoCell ® portfolio offers a comprehensive range of over 1,040 FISH probes for hematology, solid tumor, cytogenetics and rare disease, supported by our …